Entrada Therapeutics Inc (TRDA)

SG&A Expenses

$40.47M

TTM · Period ending: · USD

TRDA logo

TRDA SG&A Expenses

Latest reported$40.47M
TRDA TTM SG&A Expenses ($5.57M → $40.47M)
High-resolution chart · PNG

TRDA sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Entrada Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
40,470,000
40,900,000
41,050,000
41,359,000
41,026,000
39,340,000
38,465,000
37,258,000
34,819,000
33,752,000
32,291,000
33,533,000
32,979,000
32,144,000
30,639,000
26,843,000
23,716,000
19,463,000
15,200,000
11,099,000
8,521,000
6,587,500
5,565,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.